Aarey Drugs & Pharmaceuticals cash flow

·Pharma & HealthChart ›
Latest FY26
Cash from operations
₹10.1cr+5.0% on FY25
Capital spending
₹12.4crNo figure a year before
Free cash flow
−₹2.3cr₹9.7 cr in FY25
Cash from financing
₹2.2cr−₹3.8 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—2.91.91.71.6
—5.04.00.00.0
—25.30.10.00.0
—0.00.00.00.0
Changes in working capital
—3.9−10.8−5.9−15.1
—3.854.90.0−53.5
—0.00.05.30.0
—−13.939.5−0.90.0
—−0.2−14.4−3.228.3
—−21.0−74.81.60.2
—−0.05.13.20.0
—1.10.00.0−0.8
—0.00.00.01.0
—−0.60.0−0.10.9
Cash from operating activities
4.25.46.15.30.7
—6.35.51.9−37.6
—11.711.67.2−36.8
—1.61.9−0.72.3
—10.19.77.9−39.1
Cash from investing activities
—12.40.00.01.0
—0.00.0−1.00.0
—0.0−5.20.00.0
—0.00.0−0.70.0
—0.00.0−1.13.2
—0.00.0−0.0−9.0
—0.00.0−6.50.0
—0.0−0.70.00.0
—0.00.0−0.50.0
—0.00.00.10.0
—−12.4−5.9−7.311.1
Cash from financing activities
—0.01.72.70.0
—0.00.00.60.0
—0.00.0−5.20.0
—0.01.50.022.5
—0.04.00.00.0
—0.00.01.30.0
—2.2−0.07.40.0
—2.2−3.84.1−22.5
—−0.1−0.14.7−50.5
—−0.1−0.14.7−50.5
———5.4−50.3
Reference items
6.87.22.34.51.5
1.6%1.5%0.5%1.1%2.5%
−2.3−2.39.77.9−40.1
——9.1——
−₹0.80−₹0.80₹3.39₹2.77−₹14.11
—2.56×2.40×1.68×−79.06×
—1.61.9−0.72.3
——4.0——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

AAREYDRUGS₹108.05

Aarey Drugs & Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersNECLIFENATCAPSUQMEDICAMEQMEDICOBALPHARMAALPAKREBSBIOHALEOSLABSMcap ₹307 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation1.61.71.92.9—
+ Finance Costs0.00.04.05.0—
+ Other Non-cash Items0.00.00.125.3—
+ Other Reconciling Items0.00.00.00.0—
Changes in Working Capital
+ Inventories-15.1-5.9-10.83.9—
+ Trade Receivables — Current-53.50.054.93.8—
+ Trade Receivables — Non-current0.05.30.00.0—
+ Other Financial Assets — Current0.0-0.939.5-13.9—
+ Other Current Assets28.3-3.2-14.4-0.2—
+ Trade Payables — Current0.21.6-74.8-21.0—
+ Other Financial Liabilities — Current0.03.25.1-0.0—
+ Other Current Liabilities-0.80.00.01.1—
+ Other Non-current Liabilities1.00.00.00.0—
+ Provisions — Current0.9-0.10.0-0.6—
Cash from Operating Activities
Profit Before Tax (per I/S)0.75.36.15.44.2
+ Total Adjustments (incl. Working Capital)-37.61.95.56.3—
Cash from Operations (pre-tax)-36.87.211.611.7—
+ Income Taxes Paid2.3-0.71.91.6—
Cash from Operating Activities-39.17.99.710.1—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)1.00.00.012.4—
+ Disp of Intangible Assets0.0-1.00.00.0—
+ Disp of Investment Property0.00.0-5.20.0—
+ Acq of Other Long-term Assets0.0-0.70.00.0—
+ Disp of Other Long-term Assets3.2-1.10.00.0—
+ Loans & Advances Made-9.0-0.00.00.0—
+ Loans & Advances Repaid0.0-6.50.00.0—
+ Interest Received — Investing0.00.0-0.70.0—
+ Income Taxes (Paid) / Refund — Investing0.0-0.50.00.0—
+ Other Inflows / (Outflows) — Investing0.00.10.00.0—
Cash from Investing Activities11.1-7.3-5.9-12.4—
Cash from Financing Activities
+ Proceeds from Issue of Shares0.02.71.70.0—
+ Proceeds from Other Equity Instruments0.00.60.00.0—
+ Proceeds from Borrowings0.0-5.20.00.0—
+ Repayment of Borrowings22.50.01.50.0—
+ Interest Paid0.00.04.00.0—
+ Income Taxes (Paid) / Refund — Financing0.01.30.00.0—
+ Other Inflows / (Outflows) — Financing0.07.4-0.02.2—
Cash from Financing Activities-22.54.1-3.82.2—
Net Changes in Cash (pre-FX)-50.54.7-0.1-0.1—
Net Changes in Cash-50.54.7-0.1-0.1—
Closing Cash-50.35.4———
Reference Items
EBITDA1.54.52.37.26.8
EBITDA Margin %2.451.130.481.521.64
Free Cash Flow (CFO − Capex)-40.17.99.7-2.3-2.3
Free Cash Flow to Equity——9.1——
Free Cash Flow per Basic Share-14.112.773.39-0.80-0.80
Cash Flow to Net Income-79.061.682.402.56—
Cash Paid for Taxes2.3-0.71.91.6—
Cash Paid for Interest——4.0——
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.